| PERIOD ENDING | 30-Sep-09 | 30-Jun-09 | 31-Mar-09 | 31-Dec-08 | | Total Revenue | 458,200 | 371,631 | 397,802 | 406,593 | | Cost of Revenue | 372,367 | 300,721 | 319,620 | 328,741 | | | Gross Profit | 85,833 | 70,910 | 78,182 | 77,852 | | | Operating Expenses | | Research Development |
-
|
-
|
-
|
-
| | Selling General and Administrative | 64,492 | 55,735 | 68,059 | 69,112 | | Non Recurring |
-
|
-
|
-
|
-
| | Others | 3,923 | 3,758 | 4,307 | 4,279 | | | | Total Operating Expenses |
-
|
-
|
-
|
-
| | | | Operating Income or Loss | 17,418 | 11,417 | 5,816 | 4,461 | | | Income from Continuing Operations | | Total Other Income/Expenses Net | 24 | 252 | 1,171 | 3,643 | | Earnings Before Interest And Taxes | 17,442 | 11,669 | 6,987 | 8,104 | | Interest Expense | 5,829 | 5,082 | 6,642 | 9,574 | | Income Before Tax | 11,613 | 6,587 | 345 | (1,470) | | Income Tax Expense | 4,631 | 2,645 | 153 | (1,051) | | Minority Interest |
-
|
-
|
-
|
-
| | | | Net Income From Continuing Ops | 6,982 | 3,942 | 192 | (419) | | | Non-recurring Events | | Discontinued Operations | (1,269) | (279) | 1,137 | (3,859) | | Extraordinary Items |
-
|
-
|
-
|
-
| | Effect Of Accounting Changes |
-
|
-
|
-
|
-
| | Other Items |
-
|
-
|
-
|
-
| | | | Net Income | 5,713 | 3,663 | 1,329 | (4,278) | | Preferred Stock And Other Adjustments |
-
|
-
|
-
|
-
| | | Net Income Applicable To Common Shares | $5,713 | $3,663 | $1,329 | ($4,278) |
|
1.00% Nasdaq 0.00%
Income Statement
